Cascone, T., Bonanno, L., Guisier, F., Insa, A., Liberman, M., Bylicki, O., Livi, L., Egenod, T., Corre, R., Bielska, A. A., Yohannes, A., He, Y., Dowson, A., McGrath, L., Kar, G., Kumar, R., Grenga, I., Spicer, J., Forde, P. M. (2025). Neoadjuvant durvalumab (D) + chemotherapy (CT) + novel anticancer agents and adjuvant D ± novel agents in resectable non-small-cell lung cancer (NSCLC): Updated outcomes from NeoCOAST-2.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8046